Skip to Main Content Area
  • Event registration
  • Member Login
  • OCREB online
  • Home
  • About
  • Programs
  • Education
  • Careers
  • Contact

Annual Report 2011/12

OICR Annual Report 2011/12

OICR is an innovative translational research institute dedicated to research on the prevention, early detection, diagnosis and treatment of cancer.

Read the Annual Report: PDF [24 MB]

About

  • Annual Reports
  • Board of Directors
  • Careers
  • Corporate Fact Sheet
  • Executives
  • Media Centre
  • News
  • OICR Investigators
  • OICR Slide Deck
  • Scientific Advisory Board
  • Staff Directory
  • Strategic Plan

Programs

  • Innovation Programs
  • Cancer Stem Cells
  • Immuno- and Bio-therapies
  • Innovation in Target Validation (Terry Fox Research Institute, Ontario Node)
  • Smarter Imaging
  • Ontario Health Study
  • Technology Programs
  • Drug Discovery
  • Genetic Epidemiology and Biostatistics
  • Genome Technologies
  • Informatics and Bio-computing
  • Imaging Translation
  • Transformative Pathology
  • Translation Programs
  • Commercialization
  • Health Services Research
  • High Impact Clinical Trials
  • Other
  • Funding opportunities and research grants
  • Ontario Tumour Bank
  • Ontario Cancer Research Ethics Board (OCREB)
Close
Home → About OICR → News → Cancer News for January 13, 2012
  • News
    • News Releases
    • Portal Newsletter
    • Commercialization
    • OICR in the News
    • Cancer News

Media Contact

  • Christopher Needles
  • Manager, Strategic Communications
  • christopher [dot] needlesatoicr [dot] on [dot] ca
  • Telephone: 416-673-8505
Syndicate contentSubscribe to all news items
  • Visit the Media Centre
  • Back to About OICR

Cancer News for January 13, 2012

January 13, 2012 In: Cancer News

  • Drug shortages
    Drug Shortages Raise Risk of Cancer Counterfeits, U.S. Says
    From Bloomberg Businessweek
  • Cancer risk
    Pancreatic cancer risk increases with every 2 strips of bacon you eat: Study
    From CBS News
  • ICGC
    Agenda 2012: Decoding DNA, Cracking Cancer
    From Allianz
Permalink

About

  • Annual Reports
  • Board of Directors
  • Careers
  • Corporate Fact Sheet
  • Executives
  • Media Centre
  • News
  • OICR Investigators
  • OICR Slide Deck
  • Scientific Advisory Board
  • Staff Directory
  • Strategic Plan

Programs

  • Innovation Programs
  • Cancer Stem Cells
  • Immuno- and Bio-therapies
  • Innovation in Target Validation (Terry Fox Research Institute, Ontario Node)
  • Smarter Imaging
  • Ontario Health Study
  • Technology Programs
  • Drug Discovery
  • Genetic Epidemiology and Biostatistics
  • Genome Technologies
  • Informatics and Bio-computing
  • Imaging Translation
  • Transformative Pathology
  • Translation Programs
  • Commercialization
  • Health Services Research
  • High Impact Clinical Trials
  • Other
  • Funding opportunities and research grants
  • Ontario Tumour Bank
  • Ontario Cancer Research Ethics Board (OCREB)
  • Event Registration
  • Member Login
  • Links
  • Sitemap
  • Terms and Conditions
  • Policies and Procedures

© 2013 Ontario Institute for Cancer Research. All rights reserved.

The Government of Ontario

Funding for the Ontario Institute for Cancer Research
is provided by the Government of Ontario